Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV

Inclusion criteria

• . Are adolescent girls 12-17 years of age.
• . Are willing and able to give written informed assent with a written informed consent from a parent or legal guardian. (Amendment 01- Assent only if State allowed)
• . Are in good general health including as confirmed by a medical history and physical examination, with no known medical or mental health conditions that, in the Investigator's opinion, may interfere with study participation.
• . Willing and able to participate in the study as an outpatient, make required visits to the study center, and comply with all study requirements.
• . Have a negative urine pregnancy test result prior to study treatment initiation. In addition, female patients of childbearing potential must be using an acceptable form of birth control as determined by the Investigator (e.g., oral contraception, implantable, injectable or transdermal hormonal contraception, intrauterine device \[IUD\], double-barrier methods, have a vasectomized partner or abstinence \[if the patient becomes sexually active they must use one of the acceptable methods of birth control\]). Note: NuvaRing® or any other vaginal ring products are not permitted.
• . Have a clinical diagnosis of bacterial vaginosis, defined as having all of the following criteria:
• . Off-white (milky or gray), thin, homogeneous vaginal discharge AND
• . Vaginal pH \> 4.5 AND

Exclusion criteria